Propanc Biopharma, Inc. [PPCB] - IPO
Propanc Biopharma, Inc. is preparing for its IPO, with details on offer price and total offering size yet to be disclosed.
Why this matters
Propanc Biopharma, Inc., a pharmaceutical company incorporated in Delaware, focuses on developing treatments for cancer by utilizing proenzyme therapy, which targets and eradicates cancer stem cells. The company is preparing for an initial public offering (IPO) as part of its strategic efforts to raise capital for further development and commercialization of its products. While specific details regarding the offer price and total offering size have not been disclosed, the filing indicates the company's intent to enter the public market to support its growth initiatives.